Icon

ORFADIN (nda021232)- (2MG,5MG,10MG,20MG)

NITISINONE SWEDISH ORPHAN
2MG,5MG,10MG,20MG
No No
2013-Aug-27 Expired
None None
None No
ORFADIN is a hydroxy-phenylpyruvate dioxygenase inhibitor indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.
4 0 4
Total Other Developers 2
Drugs with Suitability No
2MG ** ** - - -
5MG ** ** - - -
10MG ** ** - - -
20MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******* ************ ******* ******* *********** **** **. *** *** ***/*, ****, **** *****,, ****, ******* ******, ***** (***) ***
****** **** ****** ****** ******* ******* *********** **** **. **/*, **, ** ** **, ***** ***, *** ***********, *********, ********* ******, ***** (***) ***
****** **** ***** *************** ******* ******* *** *********** **** **.***, **** **. *, ** ****** ****, ********, *************, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.